Primary follicular and marginal-zone lymphoma of the breast: Clinical features, prognostic factors and outcome: A study by the International Extranodal Lymphoma Study Group

Annals of Oncology

Volumn 20, Issue 12, 2009, Pages 1993-1999

  Martinelli, Giovanni ^a   Ryan, G ^b   Seymour, J F ^b   Nassi, L ^a   Steffanoni, S ^a   Alietti, A ^a   Calabrese, L ^a   Pruneri, G ^a   Santoro, L ^a   Kuper Hommel, M ^c   Tsang, R ^d   Zinzani, P L ^e   Taghian, A ^f   Zucca, E ^g   Cavalli, F ^g  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c BERNHOVEN HOSPITAL   (Netherlands)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

Breast malignancies; Follicular lymphomas; MZLs; Primary extranodal lymphomas

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DOXORUBICIN; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER REGRESSION; CANCER RELAPSE; CANCER STAGING; CAUSE SPECIFIC SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MARGINAL ZONE LYMPHOMA; OVERALL SURVIVAL; PRIMARY BREAST LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; TUMOR LOCALIZATION;

EID: 70849085837     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp238     Document Type: Article

References (29)

1. Ha CS, Dubey P, Goyal LK et al. Localized primary non-Hodgkin's lymphoma of the breast. Am J Clin Oncol 1998; 21: 376-380.
2. Giardini R, Piccolo C, Rilke F. Primary non-Hodgkin's lymphoma of the female breast. Cancer 1992; 69: 725-735.
3. Bobrow LG, Richards MA, Happerfield LC et al. Breast lymphomas: A clinicopathologic review. Hum Pathol 1993; 24: 274-278.
4. Zucca E, Conconi A, Pedrinis E et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003; 101: 2489-2495.
5. Rossi D, Berra E, Marino M et al. Histogenesis and pathogenesis of primary breast lymphoma. Blood 2004; 104: (Abstr. 1371).
6. DeBlasio D, McCormick B, Straus D et al. Definitive irradiation for localized non-Hodgkin's lymphoma of breast. Int J Radiat Oncol Biol Phys 1989; 17: 843-846.
7. Au WY, Chan AC, Chow LW, Liang R. Lymphoma of the breast in Hong Kong Chinese. Hematol Oncol 1997; 15: 33-38.
8. Domchek SM, Hecht JL, Fleming MD et al. Lymphomas of the breast: Primary and secondary involvement. Cancer 2002; 94: 6-13.
9. Wong WW, Schild SE, Halyard MY, Schomberg PJ. Primary non-Hodgkin lymphoma of the breast: The Mayo clinic experience. J Surg Oncol 2002; 80: 19-25.
10. Aviles A, Delgado S, Nambo MJ et al. Primary breast lymphoma: Results of a controlled clinical trial. Oncology 2005; 69: 256-260.
11. Ryan GF, Roos DR, Seymour JF. Primary non-Hodgkin's lymphoma of the breast: Retrospective analysis of prognosis and patterns of failure in two Australian centers. Clin Lymphoma Myeloma 2006; 6: 337-341.
12. Choo SP, Lim ST, Wong EH, Tao M. Breast lymphoma: Favorable prognosis after treatment with standard combination chemotherapy. Onkologie 2006; 29: 14-18.
13. Ganjoo K, Advani R, Mariappan MR et al. Non-Hodgkin's lymphoma of the breast. Cancer 2007; 110: 25-30.
14. Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: A model of antigen-driven lymphoproliferation. Blood 2006; 107: 3034-3044.
15. Carbone PP, Kaplan HS, Musshoff K et al. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860-1861.
16. Shipp MA, Harrington DP, Anderson JR et al. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987-994.
17. Solal-Céligny P, Roy P, Colombat P et al. Follicular lymphoma international prognostic index. Blood 2004; 104: 1258-1265.
18. Miller AB, Hoogstraten B, Staquet M et al. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
19. Jaffe E, Harris NL, Stein H et al. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press 2001.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
21. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163-170.
22. Cox DR. Regression models and life-tables. J R Stat Soc 1972; 34: 187-220.
23. Ryan G, Martinelli G, Kuper-Hommel M et al. Primary diffuse large B-cell lymphoma of the breast: Prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group. Ann Oncol 2008; 19: 233-241.
24. Yang WT, Lane DL, Le-Petross HT et al. Breast lymphoma: Imaging findings of 32 tumors in 27 patients. Radiology 2007; 245: 692-702.
25. Jennings WC, Baker RS, Murray SS et al. Primary breast lymphoma. The role of mastectomy and the importance of lymph node status. Ann Surg 2007; 245: 784-789.
26. Seymour JF, Pro B, Fuller LM et al. Long-term follow up of a prospective study of combined modality therapy for stage I-I indolent non-Hodgkin's lymphoma. J Clin Oncol 2003; 21: 2115-2122.
27. Advani R, Rosenberg SA, Horning SJ. Stage I and II follicular non-Hodgkin's lymphoma: Long-term follow-up of no initial therapy. J Clin Oncol 2004; 22: 1454-1459.
28. Marcus R, Imrie K, Belch A et al. CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma. Blood 2005; 105: 1417-1423.
29. Conconi A, Martinelli G, Thiéblemont C et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003; 102: 2741-2745.